WELL Health Technologies Corp.
WHTCF
$3.11
-$0.16-4.83%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.37% | 29.21% | 64.57% | 54.21% | 55.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.37% | 29.21% | 64.57% | 54.21% | 55.18% |
| Cost of Revenue | 9.27% | 19.81% | 37.27% | 41.15% | 44.19% |
| Gross Profit | 9.49% | 43.35% | 114.80% | 73.44% | 71.49% |
| SG&A Expenses | 21.69% | 40.86% | 37.15% | 35.54% | 39.00% |
| Depreciation & Amortization | 6.16% | 35.02% | 6.82% | 50.27% | 45.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.99% | 27.29% | 34.86% | 40.01% | 42.56% |
| Operating Income | -31.65% | 75.88% | 160.80% | 3,098.42% | 38,220.62% |
| Income Before Tax | -99.61% | 83.76% | 301.53% | 107.41% | -77.14% |
| Income Tax Expenses | 29.64% | -22.27% | -81.25% | 346.39% | 191.64% |
| Earnings from Continuing Operations | -144.65% | 86.87% | 1,851.16% | 97.03% | -84.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.25% | -55.33% | -192.63% | 500.39% | -154.45% |
| Net Income | -187.49% | 72.56% | 185.81% | 104.58% | -88.41% |
| EBIT | -31.65% | 75.88% | 160.80% | 3,098.42% | 38,220.62% |
| EBITDA | -13.97% | 50.24% | 175.19% | 228.77% | 211.63% |
| EPS Basic | -186.74% | 73.07% | 149.81% | 104.48% | -88.73% |
| Normalized Basic EPS | -220.66% | -1.52% | 73.98% | 283.61% | 141.16% |
| EPS Diluted | -186.74% | 72.81% | 160.25% | 104.48% | -88.42% |
| Normalized Diluted EPS | -222.69% | -1.52% | 73.98% | 281.15% | 142.05% |
| Average Basic Shares Outstanding | 0.93% | 1.75% | 14.30% | 1.95% | 2.85% |
| Average Diluted Shares Outstanding | -0.76% | 1.75% | 14.30% | 3.38% | 0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |